Drugs / 5,6,7,8-tetrahydrobiopterin
5,6,7,8-tetrahydrobiopterin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00260000 | Apr → Dec 2005 | phenylketonuria | The Kennedy Institute-National Eye Clinic | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5,6,7,8-tetrahydrobiopterin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00260000 ↗ |
| Known as | BH4 | “BH4, tetrahydrobiopterin, is a co-enzym for the conversion of phe to tyrosine” NCT00260000 ↗ |
| Known as | tetrahydrobiopterin | “BH4, tetrahydrobiopterin, is a co-enzym for the conversion of phe to tyrosine” NCT00260000 ↗ |
| Route | Oral | “treatment with oral BH4” NCT00260000 ↗ |